Řehulka Jiří Ph.D.

Phone: +420 585632069

Groups: DOCTORAL STUDENT, IMTM, LEM, STAFF

Assistant professor at the Institute of Molecular and Translational Medicine. He is involved in drug screening, confocal microscopy and image analysis. His research interests are microtubule targeting agents and mechanisms of resistance to antineoplastic chemotherapy drugs.

ŘEHULKA, J., N. ANNADURAI, I. FRYDRYCH, P. DŽUBÁK, M. MILLER, M. HAJDÚCH, V. DAS

Peloruside A-Induced Cell Death in Hypoxia Is p53 Dependent in HCT116 Colorectal Cancer Cells. Journal of Natural Products. 2018, 81(3), 634-640, ISSN: 0163-3864, PMID: 29400463,

OŽDIAN, T., D. HOLUB, Z. MACEČKOVÁ, L. VARANASI, G. RYLOVÁ, J. ŘEHULKA, J. VÁCLAVKOVÁ, H. SLAVÍK, P. MOUDRÝ, P. ZNOJEK, J. STANKOVÁ, J. DE SANCTIS, M. HAJDÚCH, P. DŽUBÁK

Proteomic profiling reveals DNA damage, nucleolar and ribosomal stress are the main responses to oxaliplatin treatment in cancer cells. Journal of Proteomics. 2017, 162, 73-85, ISSN: 1874-3919, PMID: 28478306,

ŘEHULKA, J., N. ANNADURAI, I. FRYDRYCH, P. ZNOJEK, P. DŽUBÁK, P. NORTHCOTE, J. MILLER, M. HAJDÚCH, V. DAS

Cellular effects of the microtubule-targeting agent peloruside A in hypoxia-conditioned colorectal carcinoma cells. Biochimica et Biophysica Acta. 2017, 17, 30124-1, ISSN: 0304-4165, PMID: 28366502,

Řehulka Jiří Ph.D.

About me

Journals